Ireland
--:--IST
Starting soon Not applicable

Role of Endoscopic Third Ventriculostomy Imanagement of Hydrocephalus in Pediatric Age Group; Clinical and Surgical Outcome

NCT07694518 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-07-12
Last updated
2026-07-13

Condition(s) studied

Hydrocephalus

Investigational drug(s) / intervention(s)

Fenestration of the floor of the third ventricleEndoscopic third ventriculostomy of the brain third ventricleEndoscopic third ventriculostomy

Fenestration of the floor of the third ventricle: Endoscopic third ventriculostomy of the third ventricle of the brain

Endoscopic third ventriculostomy of the brain third ventricle: Surgeons insert a rigid endoscope through a small burr hole in the skull into the ventricular system. They use a catheter or laser to puncture a tiny, precise opening in the floor of the third ventricle

Endoscopic third ventriculostomy: Surgeons insert a rigid endoscope through a small burr hole in the skull into the ventricular system. They use a catheter or laser to puncture a tiny, precise opening in the floor of the third ventricle

Study summary

Endoscopic third ventriculostomy in cases of hydrocephalus provide less invasive and safe technique than ventriculoperitoneal Shunt also decrease complications of ventriculoperitoneal Shunt

Eligibility

Sex
ALL
Min age
6 Months
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * cases hydrocephalus diagnosed by CT or MRI.in pediatric age group up to 18 years * Both sex (males and females) will be included. Exclusion Criteria: * cases with hydrocephalus associated with csf infection or hemorrhage * Previously operated VP shunt or ETV . * Mult cystic hydrocephalus

Primary outcome measure(s)

  • Changes in manifestation according to ETVSS endoscopic third ventriculostomy success score with assement of level of consciousness degree of papiledema and severity of headache — 6 month
    ETVSS ETV success score is predictive tool used to estimate ETV success based on factors like age etiology previous shunt other pathologies The score is expressed as a number from 0 to 90 with assement of level of consciousness degree of papiledema and severity of headache Score 70 indicate an estimated 70 % chance of success

Trial sites (1)

FacilityCityRegionStatus
Sohag University Sohag Egypt
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07694518 on ClinicalTrials.gov ↗ ← All trials in Egypt